📰 Genentech News
Page 24 - Genentech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Genentech. Real-time updates on events, politics, business and more.
March 11, 2024
Sam Altman is rejoining the board of ChatGPT-maker OpenAI along with three new directors, as the startup tries to move past his sudden ouster in November that had shocked the tech industry. ...
March 11, 2024
Sam Altman is rejoining the board of ChatGPT-maker OpenAI along with three new directors, as the startup tries to move past his sudden ouster in November that shocked the tech industry.
March 11, 2024
AI for MLR? A regulatory agency exclusively devoted to monitoring it? At SXSW, marketers let their imaginations run wild
March 11, 2024
(Reuters) - Sam Altman is rejoining the board of ChatGPT-maker OpenAI along with three new directors, as the startup tries to move past his sudden ouster in November that had shocked the tech industry.
March 11, 2024
(Reuters) - Sam Altman is rejoining the board of ChatGPT-maker OpenAI along with three new directors, as the startup tries to move past his sudden ...
March 10, 2024
As filed with the Securities and Exchange Commission on March 7, 2024 Registration No. 333- UNITED STATES SECURITIES...
March 10, 2024
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ...
March 10, 2024
A groundbreaking clinical trial sponsored and funded by the National Institutes of Health (NIH) and conducted in part at Arkansas Childrens Hospital (ACH) unveiled a pioneering treatment helping children and
March 1, 2024
Lily Ahrens was diagnosed with spinal muscular atrophy, also known as SMA. It's estimated there are more than 84,000 carriers for the genetic disease.
February 29, 2024
Longer-acting drugs, novel implants, and oral and topical agents that aim to solve the burden of frequent injections and office visits for retinal disease are on the horizon.